Comprehensive Molecular Analysis of Inflammatory Myofibroblastic Tumors Reveals Diverse Genomic Landscape and Potential Predictive Markers for Response to Crizotinib.
Che-Jui LeePatrick SchöffskiElodie ModaveJ Tom van WezelBram BoeckxJozef SufliarskyAndré B P van KuilenburgJean Yves BlayMaria Debiec-RychterRaf M E SciotJudith V M G BovéeDiether LambrechtsAgnieszka WozniakPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2021)
We identified multiple genetic alterations in archival IMFT material and provide further insight into the molecular profile of this ultra-rare, heterogeneous malignancy, which may potentially translate into novel treatment approaches for this orphan disease.